Physician profile
Danielle Lynn Shellman
NPI 1932928579
$3,824.03
in general payments reported to CMS, 2019-2025
38 companies · $3,227 in 2025
The $3,227 reported for 2025 was more than what 98% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $597 · 2025: $3,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,712 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,711.70 |
| Education | $112.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $417.28 | 2024-2025 | Fasenra, Tezspire, Breztri |
| Genzyme Corporation | $402.72 | 2024-2025 | |
| Glaxosmithkline, LLC. | $279.58 | 2024-2025 | Trelegy Ellipta, Nucala |
| Boston Scientific Corporation | $254.64 | 2025 | Watchman Flx |
| Regeneron Healthcare Solutions, INC. | $250.65 | 2024-2025 | Dupixent |
| Merck Sharp & Dohme LLC | $186.99 | 2025 | Keytruda, Winrevair, Keytruda Qlex |
| Viatris Specialty LLC | $168.86 | 2025 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $167.68 | 2024-2025 | Glassia, Hyqvia, Cuvitru |
| Boehringer Ingelheim Pharmaceuticals, INC. | $157.38 | 2025 | Ofev, Jascayd |
| Grifols USA, LLC | $148.70 | 2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $144.66 | 2025 | Ohtuvayre |
| Mallinckrodt Hospital Products INC. | $132.02 | 2024-2025 | Acthar |
| Insmed, INC. | $113.61 | 2025 | Brinsupri, Arikayce |
| Inspire Medical Systems, INC. | $112.18 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $94.95 | 2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Shellman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.